Dolors Costa

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications

Comprehensive genetic characterization of adult BCR::ABL1-negative B-ALL by Optical Genome Mapping and Targeted NGS.

Comprehensive genetic characterization of adult BCR::ABL1-negative B-ALL by Optical Genome Mapping and Targeted NGS.

Journal: Blood advances
Published: February 10, 2026

Prognostic impact of cytogenetic alterations in newly diagnosed acute myeloid leukemia treated with risk-adapted protocols.

Prognostic impact of cytogenetic alterations in newly diagnosed acute myeloid leukemia treated with risk-adapted protocols.

Journal: Medicina clinica
Published: January 24, 2025

Association of Genomic Alterations with the Presence of Serum Monoclonal Proteins in Chronic Lymphocytic Leukemia.

Association of Genomic Alterations with the Presence of Serum Monoclonal Proteins in Chronic Lymphocytic Leukemia.

Journal: Cells
Published: September 20, 2024

Prognostic significance of mutation type and chromosome fragility in Fanconi anemia.

Prognostic significance of mutation type and chromosome fragility in Fanconi anemia.

Journal: American journal of hematology
Published: July 24, 2024

Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma.

Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma.

Journal: Blood cancer journal
Published: July 09, 2024

Whole Exome Sequencing of Intermediate-Risk Acute Myeloid Leukemia without Recurrent Genetic Abnormalities Offers Deeper Insights into New Diagnostic Classifications.

Whole Exome Sequencing of Intermediate-Risk Acute Myeloid Leukemia without Recurrent Genetic Abnormalities Offers Deeper Insights into New Diagnostic Classifications.

Journal: International journal of molecular sciences
Published: June 17, 2024

Characterization of fusion transcripts in AML without recurrent genetic abnormalities unravels new putative fusion genes.

Characterization of fusion transcripts in AML without recurrent genetic abnormalities unravels new putative fusion genes.

Journal: Blood neoplasia
Published: May 06, 2024

Chronic myelomonocytic leukemia with NPM1 mutation or acute myeloid leukemia?

Chronic myelomonocytic leukemia with NPM1 mutation or acute myeloid leukemia?

Journal: The oncologist
Published: December 09, 2023

BCL3 rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases.

BCL3 rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases.

Journal: Haematologica
Published: March 23, 2023

All-CLL: A Capture-based Next-generation Sequencing Panel for the Molecular Characterization of Chronic Lymphocytic Leukemia.

All-CLL: A Capture-based Next-generation Sequencing Panel for the Molecular Characterization of Chronic Lymphocytic Leukemia.

Journal: HemaSphere
Published: March 02, 2023

Unraveling the genetics of transformed splenic marginal zone lymphoma.

Unraveling the genetics of transformed splenic marginal zone lymphoma.

Journal: Blood advances
Published: November 29, 2022

Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes.

Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes.

Journal: Cancers
Published: July 25, 2022
Showing 1-12 of 71

Last Updated: 09/26/2026